Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Albendazole Articles

BMJ: lymphatic filiarisis could be on way out

21 May 2009

BMJ: lymphatic filiarisis could be on way out

15 May 2009

10 years of drugmaker action against lymphatic filiarisis

23 February 2009

World neglected tropical disease round-up

13 October 2008

US Pres promises $350M for neglected diseases

3 March 2008

US Pres promises $350M for neglected diseases

3 March 2008

PhRMA details Mexico flood relief by members

17 December 2007

WHO stresses the need to ensure the safety of children's medicines

1 October 2007

$8.9M neglected tropical disease research boost

19 March 2007

$8.9M neglected tropical disease research boost

19 March 2007

GSK donates drug to wipe out elephantiasis

3 April 2006

Sri Lanka govt to offer free filariasis medicines for one day

4 August 2003

Analysts view Pfizer free medicine move

10 April 2000

SB partners with WHO on tropical disease

21 January 2000

SB launches diarrhea drug in Philippines

25 May 1999

SB/WTO Lymphatic Filariasis Deal

28 January 1998

USA Clears Albendazole For Parasite Infections

24 June 1996

SmithKline Beecham Unveils Power Pipeline

9 October 1995

Drug Industry Growth Held Back In Dominican republic

26 June 1995

ACT UP Accuses SB Of Unethical Conduct

19 June 1995

ESKAZOLE LAUNCH IN JAPAN

23 May 1994

JAPAN NEWS IN BRIEF

10 January 1994

DRUG FIRMS TO WORK TOGETHER ON AIDS R&D

26 April 1993

Showing 1-23 of 23 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment
  • Is failure to adopt business process management putting the pharma industry at risk?
  • New Zealand declines Alexion's funding application for Solaris
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Elan makes "transformational" acquisitions and a divestment

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS